Pharmaron Beijing Co., Ltd. (3759.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
| Market Cap | 31B |
| Enterprise Value | 33.4B |
| P/E Ratio | 49.46 |
| PEG Ratio | 1.9 |
| Price/Sales Ratio | 4.67 |
| Price/Book Ratio | 5.39 |
| Enterprise/Revenue | 5.02 |
| Enterprise/EBITDA | 22.42 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.11 |
| Operating Margin | 0.13 |
| Return On Assets | 0.06 |
| Return On Equity | 0.11 |
| Revenue | 14.1B |
| Revenue/Share | 8.27 |
| Gross Profit | 4.91B |
| EBITDA | 3.29B |
| Net Income | 1.66B |
| Diluted EPS | 0.94 |
| Total Cash | 2.45B |
| Total Cash/Share | 1.34 |
| Total Debt | 6.95B |
| Total Debt/Equity | 0.43 |
| Current Ratio | 1.02 |
| Book Value Per Share | 9.52 |
| 52-Week Change | 55.72 |
| 52-Week High | 34.86 |
| 52-Week Low | 14.45 |
| Moving Average 50 Days | 22.35 |
| Moving Average 200 Days | 20.95 |
| Average Volume | 8.54M |
| Shares Outstanding | 2.73B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.2 |
| Trailing Annual Dividend Yield | 0.42 |
| Payout Ratio | 0.29 |
| Last Split Factor | 3:2 |
| Last Split Date | July 18, 2023 |